James S. Cox, the Chief Financial Officer of Clearwater Analytics Holdings, Inc. (NYSE:CWAN), has recently disclosed the sale ...
BofA analyst Vivek Arya raised the firm’s price target on Marvell (MRVL) to $150 from $140 and keeps a Buy rating on the shares. The firm, which ...
Clearwater Analytics Holdings (CWAN – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst ...
Morgan Stanley analyst Michael Infante upgraded Clearwater Analytics (CWAN) to Overweight from Equal Weight with a price target of $34, up from ...
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ) , relating to the proposed merger with Johnson & Johnson. Under the terms of the agreement, Johnson & Johnson will acquire all outstanding shares of ...